RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma

Conditions: Primary Ocular Adnexal MALT Lymphoma Interventions: Drug: Rituximab; Radiation: Involved Site Radiation Therapy Sponsors: Zhongshan Ophthalmic Center, Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials